Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Gen Intern Med ; 24(3): 430-3, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19096898

RESUMO

Banned amphetamine-based anorectics are illicitly imported into the United States (US), but little is known regarding the harm these diet pills pose to US residents. A 26-year-old woman using imported diet pills presented with a two-year history of intermittent chest pains, palpitations, headaches and insomnia. Urine toxicology screen detected amphetamines and benzodiazepines. Fenproporex and chlordiazepoxide were detected in her pills. Her symptoms resolved after she stopped using diet pills. A 38-year-old man using imported diet pills presented after his occupational urine screen was significantly positive for amphetamine. Fenproporex and fluoxetine were detected in his pills. These cases illustrate the potential harm from imported prescription diet pills that combine fenproporex with benzodiazepines, antidepressants, diuretics, laxatives and other substances. Increasing physicians' awareness of imported diet pill use may improve care of patients suffering from the pills' many adverse effects.


Assuntos
Anfetaminas/efeitos adversos , Depressores do Apetite/efeitos adversos , Detecção do Abuso de Substâncias , Transtornos Relacionados ao Uso de Substâncias/etiologia , Adulto , Anfetaminas/provisão & distribuição , Depressores do Apetite/provisão & distribuição , Brasil , Dor no Peito/induzido quimicamente , Controle de Medicamentos e Entorpecentes , Feminino , Humanos , Masculino , Distúrbios do Início e da Manutenção do Sono/induzido quimicamente , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Taquicardia/induzido quimicamente , Estados Unidos
3.
Addiction ; 102(5): 740-51, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17506151

RESUMO

AIMS: To describe the connections among the likelihood of attention deficit/hyperactivity disorder (ADHD), medical and non-medical methylphenidate and amphetamine use and the diversion of prescribed methylphenidate in the general adolescent population. DESIGN: Cross-sectional self-reported anonymous data from the 2002 Student Drug Use Survey in the Atlantic Provinces. SETTING: The Atlantic provinces of Canada. PARTICIPANTS: A total of 12,990 students participated. MEASUREMENTS: The outcomes were a positive ADHD screening test, medical and non-medical use of methylphenidate, medical and non-medical use of amphetamine and the giving and selling of methylphenidate medication by students with a prescription. The Ontario Child Health Study Hyperactivity Scale was used to screen for ADHD. FINDINGS: The prevalence of a positive ADHD screening test was 6% with no significant gender difference. The prevalence of medical and non-medical methylphenidate use and medical and non-medical amphetamine use was 2.0%, 6.6%, 1.2% and 8.7%, respectively. A positive ADHD screening test was independently predictive of these four patterns of use. About 26% of students with prescribed methylphenidate gave or sold some of their medication. Students in a class where at least one student had given or sold some of their prescribed pills had a 1.52-fold increased risk of non-medical methylphenidate use than their counterparts in classes where no giving or selling had taken place. CONCLUSIONS: Connections were demonstrated at the population level between ADHD, medical methylphenidate use, the diversion of prescribed methylphenidate and the non-medical use of methylphenidate. The appropriate assessment and management of ADHD are essential to minimize both the risk of diversion and of substance use associated with unrecognized or untreated ADHD.


Assuntos
Anfetaminas/provisão & distribuição , Transtorno do Deficit de Atenção com Hiperatividade/epidemiologia , Estimulantes do Sistema Nervoso Central/provisão & distribuição , Metilfenidato/provisão & distribuição , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adolescente , Anfetaminas/uso terapêutico , Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico , Canadá/epidemiologia , Criança , Prescrições de Medicamentos , Feminino , Humanos , Masculino , Metilfenidato/uso terapêutico , Fatores de Risco
4.
Int J Drug Policy ; 27: 74-81, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26547299

RESUMO

BACKGROUND: Direct evidence of the effect of drug seizures on drug use and drug-related harm is fairly sparse. The aim of this study was to see whether seizures of heroin, cocaine and ATS predict the number of people arrested for use and possession of these drugs and the number overdosing on them. METHOD: We examined the effect of seizure frequency and seizure weight on arrests for drug use and possession and on the frequency of drug overdose with autoregressive distributed lag (ARDL) models. Granger causality tests were used to test for simultaneity. RESULTS: Over the short term (i.e. up to 4 months), increases in the intensity of high-level drug law enforcement (as measured by seizure weight and frequency) directed at ATS, cocaine and heroin did not appear to have any suppression effect on emergency department (ED) presentations relating to ATS, cocaine and heroin, or on arrests for use and/or possession of these drugs. A significant negative contemporaneous relationship was found between the heroin seizure weight and arrests for use and/or possession of heroin. However no evidence emerged of a contemporaneous or lagged relationship between heroin seizures and heroin ED presentations. CONCLUSION: The balance of evidence suggests that, in the Australian context, increases in the monthly seizure frequency and quantity of ATS, cocaine and heroin are signals of increased rather than reduced supply.


Assuntos
Overdose de Drogas/epidemiologia , Serviço Hospitalar de Emergência/estatística & dados numéricos , Aplicação da Lei , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Anfetaminas/efeitos adversos , Anfetaminas/provisão & distribuição , Austrália/epidemiologia , Cocaína/efeitos adversos , Cocaína/provisão & distribuição , Crime/estatística & dados numéricos , Heroína/efeitos adversos , Heroína/provisão & distribuição , Humanos , Drogas Ilícitas/efeitos adversos , Drogas Ilícitas/provisão & distribuição , Modelos Estatísticos
5.
Addiction ; 110(7): 1138-43, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25808511

RESUMO

AIMS: To investigate the temporal pattern of appearance of a new psychoactive substance (4-fluoroamphetamine) on the Dutch drug market, as well as its patterns of use and effects. DESIGN: Data from the Drug Information and Monitoring System (DIMS) was used to investigate the emergence of 4-fluoroamphetamine on the Dutch drug market. An on-line questionnaire was used to study its patterns of use and effects. SETTING: Dutch drug-related websites and social media. PARTICIPANTS: A convenience sample of 249 life-time 4-fluoroamphetamine users was recruited through the internet. MEASUREMENTS: Samples containing 4-fluoroamphetamine were extracted from the DIMS database for further investigation. Patterns of use, settings of use and the subjective effects of 4-fluoroamphetamine, amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) were investigated with the on-line questionnaire. FINDINGS: 4-Fluoroamphetamine was first encountered on the Dutch drug market, sold mainly as amphetamine or ecstasy (MDMA), between 2007 and 2009. These misrepresented drug samples declined when the MDMA and amphetamine markets recovered after a period of shortage, whereas purposefully bought 4-fluoroamphetamine samples showed an increase. Survey results showed that 4-fluoroamphetamine is used predominantly [77.1%, 95% confidence interval (CI) = 72.0-82.3] for its specific effects, rather than its legal status (17.7%, 95% CI = 10.7-22.1). The subjective effects of 4-fluoroamphetamine were compared with those of amphetamine and MDMA. Subjective effect scores of 4-fluoroamphetamine ranged between those of amphetamine and MDMA. CONCLUSIONS: The stimulant 4-fluoroamphetamine is increasingly popular in the Netherlands, which might be due to its subjective effects profile, which lies intermediate between amphetamine and MDMA.


Assuntos
Transtornos Relacionados ao Uso de Anfetaminas/epidemiologia , Anfetaminas/provisão & distribuição , Usuários de Drogas/psicologia , Drogas Ilícitas/provisão & distribuição , N-Metil-3,4-Metilenodioxianfetamina/provisão & distribuição , Psicotrópicos/provisão & distribuição , Adolescente , Adulto , Anfetaminas/efeitos adversos , Feminino , Humanos , Drogas Ilícitas/efeitos adversos , Masculino , N-Metil-3,4-Metilenodioxianfetamina/efeitos adversos , Países Baixos , Psicotrópicos/efeitos adversos , Mídias Sociais , Inquéritos e Questionários , Adulto Jovem
6.
Soc Sci Med ; 131: 297-304, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25455480

RESUMO

This article investigates everyday experiences and practises that are associated with processes of pharmaceuticalization and with practices of 'drug diversion'--that is, the illicit exchange and non-medical use of prescription drugs. It reports results from a qualitative study that was designed to examine the everyday dimensions of non-medical prescription stimulant use among students on an American university campus, which involved 38 semi-structured interviews with individuals who used prescription stimulants as a means of improving academic performance. While discussions of drug diversion are often framed in terms of broad, population-level patterns and demographic trends, the present analysis provides a complementary sociocultural perspective that is attuned to the local and everyday phenomena. Results are reported in relation to the acquisition of supplies of medications intended for nonmedical use. An analysis is provided which identifies four different sources of diverted medications (friends; family members; black-market vendors; deceived clinicians), and describes particular sets of understandings, practices and experiences that arise in relation to each different source. Findings suggest that at the level of everyday experience and practice, the phenomenon of prescription stimulant diversion is characterised by a significant degree of complexity and heterogeneity.


Assuntos
Estimulantes do Sistema Nervoso Central , Desvio de Medicamentos sob Prescrição/legislação & jurisprudência , Medicamentos sob Prescrição , Estudantes/estatística & dados numéricos , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adolescente , Anfetaminas/provisão & distribuição , Estimulantes do Sistema Nervoso Central/provisão & distribuição , Enganação , Tráfico de Drogas/legislação & jurisprudência , Tráfico de Drogas/psicologia , Feminino , Humanos , Entrevista Psicológica , Masculino , Metilfenidato/provisão & distribuição , Desvio de Medicamentos sob Prescrição/psicologia , Uso Excessivo de Medicamentos Prescritos/legislação & jurisprudência , Uso Excessivo de Medicamentos Prescritos/psicologia , Medicamentos sob Prescrição/provisão & distribuição , Pesquisa Qualitativa , Estudantes/legislação & jurisprudência , Estudantes/psicologia , Transtornos Relacionados ao Uso de Substâncias/psicologia , Adulto Jovem
7.
BMJ ; 310(6971): 20-4, 1995 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-7755714

RESUMO

OBJECTIVE: To monitor young people's knowledge and experience of illicit drugs between 1969 and 1994 at intervals of five years. DESIGN: The same anonymously completed questionnaire was used throughout. SETTING: Three Wolverhampton secondary schools representing three different socioeconomic groups. SUBJECTS: 392 pupils aged 14 to 15 completed the questionnaire in 1994. Previous sample sizes were 471 in 1969, 523 in 1974, 648 in 1979, 540 in 1984, and 380 in 1989. MAIN OUTCOME MEASURES: Self reported levels of knowledge and experience of illicit drugs. RESULTS: Over 25 years the proportion of pupils who knew someone taking drugs more than quadrupled from 15% (71/471) to 65% (254/392), and the proportion who had been offered drugs increased ninefold from 5% (24) to 45% (175). Both of these proportions more than doubled over the past five years. In 1994 the proportions of pupils mentioning "ecstasy" (methylenedioxymethamphetamine), amphetamines, and crack cocaine increased significantly (P < 0.01) and the proportion mentioning opiates decreased significantly (P < 0.01). "Poppers" (amyl nitrite) were mentioned for the first time. "To feel big, to show off, look grown up" has continued to be the main perceived reason for taking drugs. Television has continued to be the main source of information. CONCLUSIONS: In the past five years in particular young people's exposure to illicit drugs has increased dramatically. Despite more education about drugs, pupil's knowledge remains limited. Social pressures remain the first perceived reason for taking drugs. The media have a responsibility not to glamorise drugs.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Drogas Ilícitas/provisão & distribuição , Transtornos Relacionados ao Uso de Substâncias/psicologia , Adolescente , Anfetaminas/provisão & distribuição , Drogas Desenhadas/provisão & distribuição , Inglaterra/epidemiologia , Feminino , Educação em Saúde , Humanos , Drogas Ilícitas/efeitos adversos , Dietilamida do Ácido Lisérgico/provisão & distribuição , Masculino , Fumar Maconha/tendências , Entorpecentes/provisão & distribuição , Solventes/provisão & distribuição , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/epidemiologia
9.
Br J Psychiatry ; 191: 279-81, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17906235

RESUMO

Amphetamine-type stimulants are the second most widely used drugs in the world. Overprescription results in diversion for recreational use and the development of dependence. The internet plays a significant role in global misuse of amphetamine-type stimulants, permitting uncontrolled dispensing by online pharmacies and providing information on techniques for illicit manufacture.


Assuntos
Transtornos Relacionados ao Uso de Anfetaminas/epidemiologia , Anfetaminas/provisão & distribuição , Estimulantes do Sistema Nervoso Central/provisão & distribuição , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Prescrições de Medicamentos/estatística & dados numéricos , Saúde Global , Humanos , Internet , Pessoa de Meia-Idade , Farmácias/legislação & jurisprudência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA